PPARGC1A and Sepsis: Collectively, these findings support the conclusion that chiglitazar mitigates sepsis-induced lung injury through the SIRT1/PGC-1α/PPARα/GPAT3 signaling pathway. Figure 8M presents a schematic summary of our findings.